CHAAN S NG

TitleProfessor
InstitutionMD Anderson
DepartmentDiagnostic Radiology
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021 04; 9(4). PMID: 33849924.
      Citations: 6     Fields:    Translation:Humans
    2. Popnoe DO, Ng CS, Zhou S, Kaur H, Kang HC, Loyer EM, Kappadath SC, Jones AK. Comparison of virtual to true unenhanced abdominal computed tomography images acquired using rapid kV-switching dual energy imaging. PLoS One. 2020; 15(9):e0238582. PMID: 32966278.
      Citations:    Fields:    Translation:Humans
    3. Altinmakas E, Perrier ND, Grubbs EG, Lee JE, Prieto VG, Ng CS. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol. 2020 Aug; 61(8):1080-1086. PMID: 31791129.
      Citations: 3     Fields:    Translation:Humans
    4. Olivia Popnoe D, Ng CS, Zhou S, Cheenu Kappadath S, Pan T, Kyle Jones A. Comparison of enhancement quantification from virtual unenhanced images to true unenhanced images in multiphase renal Dual-Energy computed tomography: A phantom study. J Appl Clin Med Phys. 2019 Aug; 20(8):171-179. PMID: 31423728.
      Citations: 1     Fields:    Translation:Humans
    5. Halperin DM, Lee JJ, Ng CS, Strosberg JR, Estrella JS, Dagohoy CG, Dasari A, Yao JC. A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. Pancreas. 2019 03; 48(3):381-386. PMID: 30768575.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    6. Wang Y, Hu J, Ng CS, Hobbs BP. A functional model for classifying metastatic lesions integrating scans and biomarkers. Stat Methods Med Res. 2020 01; 29(1):137-150. PMID: 30672395.
      Citations:    Fields:    Translation:Humans
    7. Christakis I, Ng CS, Chen C, Yiin YH, Grubbs EG, Perrier ND, Lee JE, Graham PH. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery. 2019 03; 165(3):637-643. PMID: 30482519.
      Citations: 3     Fields:    Translation:Humans
    8. Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF. Conditional survival of patients with small renal masses undergoing active surveillance. BJU Int. 2019 03; 123(3):447-455. PMID: 30007044.
      Citations: 2     Fields:    Translation:Humans
    9. Ng CS, Kalva SP, Gunnarsson C, Ryan MP, Baker ER, Mehta RL. Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis. Cancer Imaging. 2018 Aug 24; 18(1):30. PMID: 30143056.
      Citations: 3     Fields:    Translation:Humans
    10. Altinmakas E, Üçisik-Keser FE, Medeiros LJ, Ng CS. CT and 18F- FDG-PET-CT Findings in Secondary Adrenal Lymphoma with Pathologic Correlation. Acad Radiol. 2019 06; 26(6):e108-e114. PMID: 30076085.
      Citations:    Fields:    Translation:Humans
    11. Ng CS, Wei W, Duran C, Ghosh P, Anderson EF, Chandler AG, Yao JC. CT perfusion in normal liver and liver metastases from neuroendocrine tumors treated with targeted antivascular agents. Abdom Radiol (NY). 2018 07; 43(7):1661-1669. PMID: 29075824.
      Citations: 2     Fields:    Translation:Humans
    12. Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier ND, Lee JE, Prieto VG, Hobbs BP. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol. 2018 08; 211(2):W109-W115. PMID: 29949418.
      Citations: 2     Fields:    Translation:Humans
    13. Li X, Guindani M, Ng CS, Hobbs BP. Spatial Bayesian modeling of GLCM with application to malignant lesion characterization. J Appl Stat. 2018; 46(2):230-246. PMID: 31439980.
      Citations: 4     
    14. Ghosh P, Chandler AG, Hobbs BP, Sun J, Rong J, Hong D, Subbiah V, Janku F, Naing A, Hwu WJ, Ng CS. Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors. J Comput Assist Tomogr. 2018 May/Jun; 42(3):357-364. PMID: 29189398.
      Citations:    Fields:    Translation:Humans
    15. Patnana M, Korivi BR, Devine CE, Faria S, Prieto V, Ross MI, Ng CS. Metastatic melanoma to the testis. BJR Case Rep. 2018 Mar; 4(3):20170104. PMID: 31489212.
      Citations:    
    16. Ng CS, Wei W, Altinmakas E, Li X, Ghosh P, Perrier NA, Grubbs E, Prieto VG, Lee JE, Hobbs BP. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models. AJR Am J Roentgenol. 2018 Apr; 210(4):W156-W163. PMID: 29412015.
      Citations: 3     Fields:    Translation:Humans
    17. Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier NA, Prieto VG, Lee JE, Hobbs BP. Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance. Acad Radiol. 2018 07; 25(7):861-868. PMID: 29398440.
      Citations: 3     Fields:    Translation:Humans
    18. Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V. Tree-based Methods for Characterizing Tumor Density Heterogeneity. Pac Symp Biocomput. 2018; 23:216-227. PMID: 29218883.
      Citations: 4     Fields:    Translation:Humans
    19. Ng CS, Wei W, Ghosh P, Anderson E, Herron DH, Chandler AG. Observer Variability in CT Perfusion Parameters in Primary and Metastatic Tumors in the Lung. Technol Cancer Res Treat. 2018 01 01; 17:1533034618769767. PMID: 29681221.
      Citations: 1     Fields:    Translation:Humans
    20. Mackin D, Fave X, Zhang L, Yang J, Jones AK, Ng CS, Court L. Harmonizing the pixel size in retrospective computed tomography radiomics studies. PLoS One. 2017; 12(9):e0178524. PMID: 28934225.
      Citations: 60     Fields:    Translation:Humans
    21. Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017 Jun; 43(6):785-794. PMID: 28197679.
      Citations: 16     Fields:    Translation:Humans
    22. Ng CS, Zhang Z, Lee SI, Marques HS, Burgers K, Su F, Bauza J, Mannel RS, Walker JL, Huh WK, Rubin SC, DiSilvestro P, Martin LP, Chan JK, Bookman MA, Coleman RL, Lee TY. CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study. Clin Cancer Res. 2017 Jul 15; 23(14):3684-3691. PMID: 28174234.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    23. Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY). 2017 02; 42(2):577-584. PMID: 27665482.
      Citations: 2     Fields:    Translation:Humans
    24. Fronczyk KM, Guindani M, Hobbs BP, Ng CS, Vannucci M. A Bayesian Nonparametric Approach for Functional Data Classification with Application to Hepatic Tissue Characterization. Cancer Inform. 2015; 14(Suppl 5):151-62. PMID: 27279730.
      Citations:    
    25. Ghosh P, Chandler AG, Altinmakas E, Rong J, Ng CS. Correction of Motion Artifacts From Shuttle Mode Computed Tomography Acquisitions for Body Perfusion Imaging Applications. J Comput Assist Tomogr. 2016 May-Jun; 40(3):471-7. PMID: 27192503.
      Citations: 1     Fields:    Translation:Humans
    26. Khawaja MR, Nick AM, Madhusudanannair V, Fu S, Hong D, McQuinn LM, Ng CS, Piha-Paul SA, Janku F, Subbiah V, Tsimberidou A, Karp D, Meric-Bernstam F, Lu KH, Naing A. Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers. Cancer Chemother Pharmacol. 2016 05; 77(5):973-7. PMID: 27014780.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    27. Yang J, Zhang L, Fave XJ, Fried DV, Stingo FC, Ng CS, Court LE. Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors. Comput Med Imaging Graph. 2016 Mar; 48:1-8. PMID: 26745258.
      Citations: 18     Fields:    Translation:Humans
    28. Tannir NM, Jonasch E, Albiges L, Altinmakas E, Ng CS, Matin SF, Wang X, Qiao W, Dubauskas Lim Z, Tamboli P, Rao P, Sircar K, Karam JA, McDermott DF, Wood CG, Choueiri TK. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial. Eur Urol. 2016 05; 69(5):866-74. PMID: 26626617.
      Citations: 97     Fields:    Translation:HumansCTClinical Trials
    29. Wang Y, Hobbs BP, Ng CS. CT Perfusion Characteristics Identify Metastatic Sites in Liver. Biomed Res Int. 2015; 2015:120749. PMID: 26509144.
      Citations: 3     Fields:    Translation:Humans
    30. Ng CS, Wei W, Bankson JA, Ravoori MK, Han L, Brammer DW, Klumpp S, Waterton JC, Jackson EF. Dependence of DCE-MRI biomarker values on analysis algorithm. PLoS One. 2015; 10(7):e0130168. PMID: 26208254.
      Citations: 11     Fields:    Translation:AnimalsCells
    31. Altinmakas E, Guo M, Kundu UR, Habra MA, Ng C. Computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis: two cases. Clin Imaging. 2015 Nov-Dec; 39(6):1115-8. PMID: 26298420.
      Citations: 1     Fields:    Translation:Humans
    32. Vodopivec DM, Habra MA, Ng C, Sircar K, Grubbs EG. Visual Vignette. Endocr Pract. 2015 Jul; 21(7):854. PMID: 26121444.
      Citations:    Fields:    Translation:Humans
    33. Hobbs BP, Ng CS. Inferring Stable Acquisition Durations for Applications of Perfusion Imaging in Oncology. Cancer Inform. 2015; 14(Suppl 2):193-9. PMID: 26052222.
      Citations: 1     
    34. Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH. Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. Lancet Oncol. 2015 Jun; 16(6):695-703. PMID: 25956795.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    35. Ng CS, Hobbs BP, Wei W, Anderson EF, Herron DH, Yao JC, Chandler AG. Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver. J Comput Assist Tomogr. 2015 May-Jun; 39(3):373-82. PMID: 25626401.
      Citations: 4     Fields:    Translation:Humans
    36. Wang Y, Hobbs BP, Hu J, Ng CS, Do KA. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Biometrics. 2015 Sep; 71(3):792-802. PMID: 25851056.
      Citations: 3     Fields:    Translation:Humans
    37. Shah AY, Karam JA, Lim ZD, Ng CS, Tannir NM. Clinical and pathological complete remission in a patient with metastatic renal cell carcinoma (mRCC) treated with sunitinib: Is mRCC curable with targeted therapy? Urol Case Rep. 2015 Mar 01; 3(2):18-20. PMID: 26120560.
      Citations: 2     
    38. Yao JC, Phan AT, Hess K, Fogelman D, Jacobs C, Dagohoy C, Leary C, Xie K, Ng CS. Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors. Pancreas. 2015 Mar; 44(2):190-7. PMID: 25426617.
      Citations: 19     Fields:    Translation:Humans
    39. Bilen MA, Fu S, Falchook GS, Ng CS, Wheler JJ, Abdelrahim M, Erguvan-Dogan B, Hong DS, Tsimberidou AM, Kurzrock R, Naing A. Phase I trial of valproic acid and lenalidomide in patients with advanced cancer. Cancer Chemother Pharmacol. 2015 Apr; 75(4):869-74. PMID: 25666183.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    40. Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R. Targeting hypoxia-inducible factor-1a (HIF-1a) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. Oncotarget. 2014 Nov 15; 5(21):10280-92. PMID: 25373733.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    41. Ng CS, Chandler AG, Yao JC, Herron DH, Anderson EF, Charnsangavej C, Hobbs BP. Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors. J Comput Assist Tomogr. 2014 Jul-Aug; 38(4):526-34. PMID: 24651739.
      Citations: 4     Fields:    Translation:Humans
    42. Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg. 2014 Jun; 38(6):1318-27. PMID: 24615603.
      Citations: 7     Fields:    Translation:Humans
    43. Carthon BC, Ng CS, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis. BJU Int. 2014 Jun; 113(6):871-7. PMID: 24053151.
      Citations: 26     Fields:    Translation:Humans
    44. Atkinson BJ, Cauley DH, Ng C, Millikan RE, Xiao L, Corn P, Jonasch E, Tannir NM. Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes. BJU Int. 2014 Mar; 113(3):376-82. PMID: 24053120.
      Citations: 20     Fields:    Translation:Humans
    45. Ng CS, Hobbs BP, Chandler AG, Anderson EF, Herron DH, Charnsangavej C, Yao J. Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. Radiology. 2013 Dec; 269(3):758-67. PMID: 23824990.
      Citations: 15     Fields:    Translation:Humans
    46. Richey SL, Tamboli P, Ng CS, Lin E, Lim ZD, Araujo JC, Jonasch E, Sharma P, Pagliaro LC, Tannir NM. Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol. 2013 Oct; 36(5):450-4. PMID: 22706175.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    47. Ng CS, Chandler AG, Wei W, Anderson EF, Herron DH, Kurzrock R, Charnsangavej C. Effect of duration of scan acquisition on CT perfusion parameter values in primary and metastatic tumors in the lung. Eur J Radiol. 2013 Oct; 82(10):1811-8. PMID: 23769187.
      Citations: 3     Fields:    Translation:Humans
    48. Conter HJ, Lim ZD, Ng CS, Millikan RE, Tannir NM. Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission. Clin Genitourin Cancer. 2013 Sep; 11(3):370-3. PMID: 23665133.
      Citations:    Fields:    Translation:Humans
    49. Ng CS, Chandler AG, Wei W, Anderson EF, Herron DH, Kurzrock R, Charnsangavej C. Effect of sampling frequency on perfusion values in perfusion CT of lung tumors. AJR Am J Roentgenol. 2013 Feb; 200(2):W155-62. PMID: 23345379.
      Citations: 7     Fields:    Translation:Humans
    50. Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg. 2013 Feb; 216(2):280-9. PMID: 23317575.
      Citations: 17     Fields:    Translation:Humans
    51. Kim KB, Prieto V, Joseph RW, Diwan AH, Gallick GE, Papadopoulos NE, Bedikian AY, Camacho LH, Hwu P, Ng CS, Wei W, Johnson MM, Wittemer SM, Vardeleon A, Reckeweg A, Colevas AD. A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Res. 2012 Aug; 22(4):294-301. PMID: 22668797.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    52. Ng CS, Chandler AG, Wei W, Anderson EF, Herron DH, Kurzrock R, Charnsangavej C. Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver. J Comput Assist Tomogr. 2012 Jul-Aug; 36(4):388-93. PMID: 22805665.
      Citations: 7     Fields:    Translation:Humans
    53. Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao L, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E. A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. Eur Urol. 2012 Dec; 62(6):1013-9. PMID: 22771265.
      Citations: 55     Fields:    Translation:HumansCTClinical Trials
    54. Jain RK, Lee JJ, Ng C, Hong D, Gong J, Naing A, Wheler J, Kurzrock R. Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies. J Clin Oncol. 2012 Jul 20; 30(21):2684-90. PMID: 22689801.
      Citations: 38     Fields:    Translation:Humans
    55. Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC, Mills GB. Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol. 2012 Jul; 126(1):47-53. PMID: 22487539.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    56. Bronstein Y, Ng CS, Rohren E, Ross MI, Lee JE, Cormier J, Johnson VE, Hwu WJ. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012 Apr; 198(4):902-8. PMID: 22451559.
      Citations: 11     Fields:    Translation:Humans
    57. Ng CS, Waterton JC, Kundra V, Brammer D, Ravoori M, Han L, Wei W, Klumpp S, Johnson VE, Jackson EF. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat. 2012 Jun; 11(3):279-88. PMID: 22417064.
      Citations: 13     Fields:    Translation:Animals
    58. Katabathina VS, Lassau N, Pedrosa I, Ng CS, Prasad SR. Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging. Curr Urol Rep. 2012 Feb; 13(1):70-81. PMID: 22143974.
      Citations: 4     Fields:    Translation:Humans
    59. Davies MA, Fox PS, Papadopoulos NE, Bedikian AY, Hwu WJ, Lazar AJ, Prieto VG, Culotta KS, Madden TL, Xu Q, Huang S, Deng W, Ng CS, Gupta S, Liu W, Dancey JE, Wright JJ, Bassett RL, Hwu P, Kim KB. Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma. Clin Cancer Res. 2012 Feb 15; 18(4):1120-8. PMID: 22223528.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    60. Joseph RW, Sullivan RJ, Harrell R, Stemke-Hale K, Panka D, Manoukian G, Percy A, Bassett RL, Ng CS, Radvanyi L, Hwu P, Atkins MB, Davies MA. Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma. J Immunother. 2012 Jan; 35(1):66-72. PMID: 22130161.
      Citations: 51     Fields:    Translation:Humans
    61. Jakob JA, Bassett RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer. 2012 Aug 15; 118(16):4014-23. PMID: 22180178.
      Citations: 254     Fields:    Translation:Humans
    62. Bronstein Y, Ng CS, Hwu P, Hwu WJ. Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy. AJR Am J Roentgenol. 2011 Dec; 197(6):W992-W1000. PMID: 22109345.
      Citations: 68     Fields:    Translation:Humans
    63. Coleman RL, Duska LR, Ramirez PT, Heymach JV, Kamat AA, Modesitt SC, Schmeler KM, Iyer RB, Garcia ME, Miller DL, Jackson EF, Ng CS, Kundra V, Jaffe R, Sood AK. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol. 2011 Nov; 12(12):1109-17. PMID: 21992853.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    64. Matrana MR, Ng C, Rao P, Lim ZD, Tannir NM. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report. Clin Genitourin Cancer. 2011 Dec; 9(2):137-9. PMID: 21831725.
      Citations: 1     Fields:    Translation:Humans
    65. Ng CS, Chandler AG, Wei W, Herron DH, Anderson EF, Kurzrock R, Charnsangavej C. Reproducibility of CT perfusion parameters in liver tumors and normal liver. Radiology. 2011 Sep; 260(3):762-70. PMID: 21788525.
      Citations: 24     Fields:    Translation:Humans
    66. Naing A, Kurzrock R, Burger A, Gupta S, Lei X, Busaidy N, Hong D, Chen HX, Doyle LA, Heilbrun LK, Rohren E, Ng C, Chandhasin C, LoRusso P. Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res. 2011 Sep 15; 17(18):6052-60. PMID: 21750201.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    67. Ng CS, Chandler AG, Wei W, Anderson EF, Herron DH, Charnsangavej C, Kurzrock R. Reproducibility of perfusion parameters obtained from perfusion CT in lung tumors. AJR Am J Roentgenol. 2011 Jul; 197(1):113-21. PMID: 21701018.
      Citations: 20     Fields:    Translation:Humans
    68. Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Müller T, Ratain MJ, Salgia R. Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol. 2011 Jul 01; 29(19):2660-6. PMID: 21606412.
      Citations: 200     Fields:    Translation:HumansCTClinical Trials
    69. Fu S, Naing A, Moulder SL, Culotta KS, Madoff DC, Ng CS, Madden TL, Falchook GS, Hong DS, Kurzrock R. Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity. Mol Cancer Ther. 2011 Jul; 10(7):1300-7. PMID: 21571911.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    70. Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg. 2011 Apr; 212(4):659-65; discussion 665-7. PMID: 21463807.
      Citations: 11     Fields:    Translation:Humans
    71. Chandler A, Wei W, Herron DH, Anderson EF, Johnson VE, Ng CS. Semiautomated motion correction of tumors in lung CT-perfusion studies. Acad Radiol. 2011 Mar; 18(3):286-93. PMID: 21295733.
      Citations: 13     Fields:    Translation:Humans
    72. Ng CS, Charnsangavej C, Wei W, Yao JC. Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy. AJR Am J Roentgenol. 2011 Mar; 196(3):569-76. PMID: 21343498.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    73. Tian M, Wen X, Jackson EF, Ng C, Uthamanthil R, Liang D, Gelovani JG, Li C. Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. Contrast Media Mol Imaging. 2011 Jul-Aug; 6(4):289-97. PMID: 21861289.
      Citations: 5     Fields:    Translation:Animals
    74. Richey SL, Ng C, Lim ZD, Jonasch E, Tannir NM. Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy. J Clin Oncol. 2011 Mar 10; 29(8):e203-5. PMID: 21172884.
      Citations: 9     Fields:    Translation:Humans
    75. Camacho LH, Garcia S, Panchal AM, Lim J, Hong DS, Ng C, Madoff DC, Fu S, Gayed I, Kurzrock R. Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases. Clin Colorectal Cancer. 2010 Dec; 9(5):311-4. PMID: 21208846.
      Citations: 1     Fields:    Translation:Humans
    76. Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM. Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR Am J Roentgenol. 2010 Oct; 195(4):959-65. PMID: 20858825.
      Citations: 10     Fields:    Translation:Humans
    77. Tsimberidou AM, Fu S, Ng C, Lim JA, Wen S, Hong D, Wheler J, Bedikian AY, Eng C, Wallace M, Camacho LH, Kurzrock R. A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. Cancer. 2010 Sep 01; 116(17):4086-94. PMID: 20564148.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    78. Melancon MP, Lu W, Huang Q, Thapa P, Zhou D, Ng C, Li C. Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813. Biomaterials. 2010 Sep; 31(25):6567-73. PMID: 20537382.
      Citations: 24     Fields:    Translation:AnimalsCells
    79. Vaklavas C, Tsimberidou AM, Wen S, Hong D, Wheler J, Ng CS, Naing A, Uehara C, Wolff RA, Kurzrock R. Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience. Cancer. 2011 Jan 01; 117(1):77-85. PMID: 20737567.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    80. Samuels J, Ng CS, Nates J, Price K, Finkel K, Salahudeen A, Shaw A. Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer. Support Care Cancer. 2011 Oct; 19(10):1527-32. PMID: 20711842.
      Citations: 13     Fields:    Translation:Humans
    81. Ng CS, Shaw AD, Bell CS, Samuels JA. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol. 2010 Aug; 195(2):414-22. PMID: 20651198.
      Citations: 14     Fields:    Translation:Humans
    82. Ng CS, Palmer CR. Analysis of diagnostic confidence: application to data from a prospective randomized controlled trial of CT for acute abdominal pain. Acta Radiol. 2010 May; 51(4):368-74. PMID: 20350244.
      Citations: 4     Fields:    Translation:Humans
    83. Ravoori M, Czaplinska AJ, Sikes C, Han L, Johnson EM, Qiao W, Ng C, Cody DD, Murphy WA, Do KA, Navone NM, Kundra V. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One. 2010 Mar 29; 5(3):e9854. PMID: 20360964.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    84. Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R. Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. Cancer Chemother Pharmacol. 2010 Nov; 66(6):1087-93. PMID: 20204368.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    85. Ng CS, Raunig DL, Jackson EF, Ashton EA, Kelcz F, Kim KB, Kurzrock R, McShane TM. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol. 2010 Feb; 194(2):W134-40. PMID: 20093564.
      Citations: 27     Fields:    Translation:Humans
    86. Ng CS, Wang X, Faria SC, Lin E, Charnsangavej C, Tannir NM. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon. AJR Am J Roentgenol. 2010 Jan; 194(1):166-71. PMID: 20028919.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    87. Tsimberidou AM, Rudek MA, Hong D, Ng CS, Blair J, Goldsweig H, Kurzrock R. Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors. Cancer Chemother Pharmacol. 2010 Jan; 65(2):235-41. PMID: 19484470.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    88. Jonasch E, Corn P, Pagliaro LC, Warneke CL, Johnson MM, Tamboli P, Ng C, Aparicio A, Ashe RG, Wright JJ, Tannir NM. Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer. 2010 Jan 01; 116(1):57-65. PMID: 19862815.
      Citations: 55     Fields:    Translation:HumansCTClinical Trials
    89. Hong DS, Sebti SM, Newman RA, Blaskovich MA, Ye L, Gagel RF, Moulder S, Wheler JJ, Naing A, Tannir NM, Ng CS, Sherman SI, El Naggar AK, Khan R, Trent J, Wright JJ, Kurzrock R. Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res. 2009 Nov 15; 15(22):7061-8. PMID: 19903778.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    90. Tsimberidou AM, Vaklavas C, Wen S, Hong D, Wheler J, Ng C, Naing A, Tse S, Busaidy N, Markman M, Sherman SI, Kurzrock R. Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience. J Clin Endocrinol Metab. 2009 Nov; 94(11):4423-32. PMID: 19820016.
      Citations: 17     Fields:    Translation:Humans
    91. Tsimberidou AM, Camacho LH, Verstovsek S, Ng C, Hong DS, Uehara CK, Gutierrez C, Daring S, Stevens J, Komarnitsky PB, Schwartz B, Kurzrock R. A phase I clinical trial of darinaparsin in patients with refractory solid tumors. Clin Cancer Res. 2009 Jul 15; 15(14):4769-76. PMID: 19584162.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    92. Moulder S, Dhillon N, Ng C, Hong D, Wheler J, Naing A, Tse S, La Paglia A, Dorr R, Hersh E, Boytim M, Kurzrock R. A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. Invest New Drugs. 2010 Oct; 28(5):634-40. PMID: 19499186.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    93. Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol. 2009 Jun; 192(6):1488-93. PMID: 19457809.
      Citations: 20     Fields:    Translation:Humans
    94. Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am J Roentgenol. 2009 Jun; 192(6):1481-7. PMID: 19457808.
      Citations: 19     Fields:    Translation:Humans
    95. Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics. 2009 May-Jun; 29(3):741-54; discussion 755-7. PMID: 19448113.
      Citations: 35     Fields:    Translation:Humans
    96. Ng CS, Kodama Y, Mullani NA, Barron BJ, Wei W, Herbst RS, Abbruzzese JL, Charnsangavej C. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study. J Comput Assist Tomogr. 2009 May-Jun; 33(3):460-5. PMID: 19478644.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    97. Kim KB, Hwu WJ, Papadopoulos NE, Bedikian AY, Camacho LH, Ng C, Hernandez IM, Frost AM, Jack MA, Hwu P. Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma. Cancer Chemother Pharmacol. 2009 Jun; 64(1):161-7. PMID: 19002462.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    98. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol. 2008 Oct; 191(4):1220-32. PMID: 18806169.
      Citations: 58     Fields:    Translation:HumansPHPublic Health
    99. Ashton E, Raunig D, Ng C, Kelcz F, McShane T, Evelhoch J. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging. 2008 Sep; 28(3):791-6. PMID: 18777526.
      Citations: 23     Fields:    Translation:Humans
    100. Tannir NM, Thall PF, Ng CS, Wang X, Wooten L, Siefker-Radtke A, Mathew P, Pagliaro L, Wood C, Jonasch E. A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents. J Urol. 2008 Sep; 180(3):867-72; discussion 872. PMID: 18635226.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    101. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008 Jul 15; 14(14):4491-9. PMID: 18628464.
      Citations: 372     Fields:    Translation:HumansCTClinical Trials
    102. Ng CS, Palmer CR. Assessing diagnostic confidence: a comparative review of analytical methods. Acad Radiol. 2008 May; 15(5):584-92. PMID: 18423315.
      Citations: 3     Fields:    Translation:Humans
    103. Osai WE, Ng CS, Pagliaro LC. Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma. Anticancer Drugs. 2008 Apr; 19(4):427-9. PMID: 18454053.
      Citations: 5     Fields:    Translation:Humans
    104. Yao JC, Phan A, Hoff PM, Chen HX, Charnsangavej C, Yeung SC, Hess K, Ng C, Abbruzzese JL, Ajani JA. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol. 2008 Mar 10; 26(8):1316-23. PMID: 18323556.
      Citations: 131     Fields:    Translation:HumansCTClinical Trials
    105. Beddar AS, Briere TM, Balter P, Pan T, Tolani N, Ng C, Szklaruk J, Krishnan S. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol. 2008 Jun; 87(3):445-8. PMID: 18194819.
      Citations: 25     Fields:    Translation:Humans
    106. Ng CS, Wei W, Doyle TC, Courtney HM, Dixon AK, Freeman AH. Minimal-preparation abdomino-pelvic CT in frail and elderly patients: prognostic value of colonic and extracolonic findings. Clin Radiol. 2008 Apr; 63(4):424-32. PMID: 18325363.
      Citations:    Fields:    Translation:Humans
    107. Krishnan S, Briere TM, Dong L, Murthy R, Ng C, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys. 2007 Dec; 34(12):4591-3. PMID: 18196785.
      Citations: 1     Fields:    Translation:Humans
    108. Gonzalez RJ, Tamm EP, Ng C, Phan AT, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Surgery. 2007 Dec; 142(6):867-75; discussion 867-75. PMID: 18063070.
      Citations: 17     Fields:    Translation:Humans
    109. Faria SC, Ng CS, Hess KR, Phongkitkarun S, Szejnfeld J, Daliani D, Charnsangavej C. CT quantification of effects of thalidomide in patients with metastatic renal cell carcinoma. AJR Am J Roentgenol. 2007 Aug; 189(2):378-85. PMID: 17646464.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    110. Rosen LS, Kurzrock R, Mulay M, Van Vugt A, Purdom M, Ng C, Silverman J, Koutsoukos A, Sun YN, Bass MB, Xu RY, Polverino A, Wiezorek JS, Chang DD, Benjamin R, Herbst RS. Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors. J Clin Oncol. 2007 Jun 10; 25(17):2369-76. PMID: 17557949.
      Citations: 67     Fields:    Translation:HumansCTClinical Trials
    111. Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am. 2007 Jun; 21(3):409-32; vii. PMID: 17548032.
      Citations: 25     Fields:    Translation:Humans
    112. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007 May; 188(5):1307-12. PMID: 17449775.
      Citations: 150     Fields:    Translation:Humans
    113. Jackson EF, Esparza-Coss E, Wen X, Ng CS, Daniel SL, Price RE, Rivera B, Charnsangavej C, Gelovani JG, Li C. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):830-8. PMID: 17379450.
      Citations: 16     Fields:    Translation:AnimalsPHPublic Health
    114. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007 Jan; 14(1):14-24. PMID: 17072676.
      Citations: 90     Fields:    Translation:Humans
    115. Kundra V, Ng CS, Ma J, Bankson JA, Price RE, Cody DD, Do KA, Han L, Navone NM. In vivo imaging of prostate cancer involving bone in a mouse model. Prostate. 2007 Jan 01; 67(1):50-60. PMID: 17031813.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    116. Tannir NM, Cohen L, Wang X, Thall P, Mathew PF, Jonasch E, Siefker-Radtke A, Pagliaro LC, Ng CS, Logothetis C. Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma. Cancer. 2006 Nov 01; 107(9):2254-61. PMID: 17029276.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    117. Bedi DG, Gombos DS, Ng CS, Singh S. Sonography of the eye. AJR Am J Roentgenol. 2006 Oct; 187(4):1061-72. PMID: 16985158.
      Citations: 11     Fields:    Translation:Humans
    118. Aloia TA, Gershenwald JE, Andtbacka RH, Johnson MM, Schacherer CW, Ng CS, Cormier JN, Lee JE, Ross MI, Mansfield PF. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol. 2006 Jun 20; 24(18):2858-65. PMID: 16782925.
      Citations: 10     Fields:    Translation:Humans
    119. Ng CS. Radiologic diagnosis and staging of renal and bladder cancer. Semin Roentgenol. 2006 Apr; 41(2):121-38. PMID: 16697891.
      Citations: 5     Fields:    Translation:Humans
    120. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol. 2006 Mar 01; 24(7):1145-51. PMID: 16505434.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    121. Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol. 2006 Apr; 13(4):542-6. PMID: 16474907.
      Citations: 7     Fields:    Translation:Humans
    122. Braiteh F, Ng C, Kurzrock R. Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin). Leuk Lymphoma. 2006 Feb; 47(2):373-5. PMID: 16321875.
      Citations: 2     Fields:    Translation:Humans
    123. Liu G, Rugo HS, Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT, Charnsangavej C, Park JW, Ashton EA, Steinfeldt HM, Pithavala YK, Reich SD, Herbst RS. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol. 2005 Aug 20; 23(24):5464-73. PMID: 16027440.
      Citations: 69     Fields:    Translation:HumansCTClinical Trials
    124. Kazama T, Ng CS, Giralt SA. Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging. 2005 Jul-Aug; 29(4):263-5. PMID: 15967318.
      Citations: 4     Fields:    Translation:Humans
    125. Leibovici D, Kamat AM, Do KA, Pettaway CA, Ng CS, Evans RB, Rodriguez-Bigas M, Skibber J, Wang X, Pisters LL. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4. PMID: 15389800.
      Citations: 6     Fields:    Translation:Humans
    126. Kobayashi S, Ng CS, Kazama T, Madoff DC, Faria SC, Vauthey JN, Charnsangavej C. Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomogr. 2004 Nov-Dec; 28(6):804-10. PMID: 15538155.
      Citations: 3     Fields:    Translation:Humans
    127. Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De Rosa V, Cremona F, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA, Ng C, Curley SA. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol. 2004 May 15; 22(10):1815-22. PMID: 15143074.
      Citations: 90     Fields:    Translation:HumansCTClinical Trials
    128. Ng CS, Doyle TC, Courtney HM, Campbell GA, Freeman AH, Dixon AK. Extracolonic findings in patients undergoing abdomino-pelvic CT for suspected colorectal carcinoma in the frail and disabled patient. Clin Radiol. 2004 May; 59(5):421-30. PMID: 15081847.
      Citations: 7     Fields:    Translation:Humans
    129. O'Donohue J, Ng C, Catnach S, Farrant P, Williams R. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol. 2004 Feb; 16(2):147-55. PMID: 15075987.
      Citations: 15     Fields:    Translation:Humans
    130. Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, McNeese M, Selwyn BJ, Spitz MR, Bondy ML. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003 Oct 01; 98(7):1457-64. PMID: 14508833.
      Citations: 22     Fields:    Translation:Humans
    131. Ng CS, Watson CJ, Palmer CR, See TC, Beharry NA, Housden BA, Bradley JA, Dixon AK. Evaluation of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study. BMJ. 2002 Dec 14; 325(7377):1387. PMID: 12480851.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    132. Ng CS, Doyle TC, Pinto EM, Courtney HM, Bull RK, Prevost AT, Campbell GA, Freeman AH, Dixon AK. Evaluation of CT in identifying colorectal carcinoma in the frail and disabled patient. Eur Radiol. 2002 Dec; 12(12):2988-97. PMID: 12439581.
      Citations: 5     Fields:    Translation:Humans
    133. Ng CS, Doyle TC, Pinto EM, Courtney HM, Miller R, Bull RK, Freeman AH, Dixon AK. Caecal carcinomas in the elderly: useful signs in minimal preparation CT. Clin Radiol. 2002 May; 57(5):359-64. PMID: 12014932.
      Citations: 4     Fields:    Translation:Humans
    134. Ng CS, Hall CM. Costochondral junction fractures and intra-abdominal trauma in non-accidental injury (child abuse). Pediatr Radiol. 1998 Sep; 28(9):671-6. PMID: 9732490.
      Citations: 3     Fields:    Translation:Humans
    135. Ng C, Phongsathorn V, Mitchell S. Doctors should be trained in lifting patients. BMJ. 1997 Aug 30; 315(7107):550-1. PMID: 9329331.
      Citations:    Fields:    Translation:Humans
    136. Ng CS, Hall CM, Shaw DG. The range of visceral manifestations of non-accidental injury. Arch Dis Child. 1997 Aug; 77(2):167-74. PMID: 9301362.
      Citations: 5     Fields:    Translation:Humans
    137. Inferring stable acquisition durations for applications of perfusion imaging in oncology. Cancer Informatics. 14:193-199.
    138. MDCT. Applied Radiology. 42:24-34.
    139. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Biometrics.
    140. Bladder cancer and upper tracts. 311-333.
    141. Melanoma. 633-652.
    142. The role of imaging in the management of primary pleural malignancies. Cancer Imaging. 3:139-145.
    143. Clinical and pathological complete remission in a patient with metastatic renal cell carcinoma (mrcc) treated with sunitinib. Urology Case Reports. 3:18-20.
    144. CT perfusion characteristics identify metastatic sites in liver. BioMed Research International. 2015.
    145. Case report. Brain and Language. 51:735-736.
    146. Computed tomography and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis. Clinical Imaging.
    147. Authors' response. Radiographics. 29:757.
    148. CT and ultrasound appearances of appendicitis. Radiology Now. 21:15-19.
    149. Portal vein embolization. Current Medical Imaging Reviews. 2:385-404.
    150. Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers. Cancer Chemotherapy and Pharmacology. 1-5.
    151. Incidental extracolonic lesions. 339-354.
    152. Dependence of DCE-MRI biomarker values on analysis algorithm. PLoS One. 10.
    153. Correction of Motion Artifacts From Shuttle Mode Computed Tomography Acquisitions for Body Perfusion Imaging Applications. Journal of Computer Assisted Tomography.
    154. Computed tomography in acute abdomen. CME Journal Radiology. 4:92-95.
    155. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN). European Urology.
    156. Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors. Computerized Medical Imaging and Graphics. 48:1-8.
    157. Bone biopsies. Imaging. 12:171-177.
    158. Abdominal Radiology. 1-8.
    159. Accuracy of computed tomography for identifying locally advanced disease in patients with muscle-invasive bladder cancer. UroToday International Journal. 6.
    NG's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (452)
    Explore
    _
    Co-Authors (133)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _